115 related articles for article (PubMed ID: 7190894)
21. Meal-stimulated gastrin release and calcitonin secretion.
Pedrazzoni M; Ciotti G; Davoli L; Pioli G; Girasole G; Palummeri E; Passeri M
J Endocrinol Invest; 1989 Jun; 12(6):409-12. PubMed ID: 2768761
[TBL] [Abstract][Full Text] [Related]
22. Release of calcitonin by cultures of medullary carcinoma of the thyroid.
Lichtenberger LM; Singer FR
Endocr Res Commun; 1975; 2(8):527-36. PubMed ID: 1222721
[TBL] [Abstract][Full Text] [Related]
23. [Calcitonin as a tumor marker. I. Medullary carcinoma of the thyroid].
Galán Galán F; Garrido Peralta M
Rev Clin Esp; 1982 Apr; 165(1):5-9. PubMed ID: 7122936
[No Abstract] [Full Text] [Related]
24. Calcitonin gene-related peptide as a tumor marker for medullary thyroid carcinoma.
Takami H; Ito K
Int Surg; 1992; 77(3):181-5. PubMed ID: 1399365
[TBL] [Abstract][Full Text] [Related]
25. [Calcitonin and its significance for the diagnosis of medullary carcinoma of the thyroid].
Gautvik KM
Tidsskr Nor Laegeforen; 1973 May; 93(15):1143-8. PubMed ID: 4584540
[No Abstract] [Full Text] [Related]
26. Calcitonin secretion in medullary carcinoma of the thyroid.
Frölich M; Heersche JN; Lemkes HH; Thesingh CW
Horm Metab Res; 1972 Sep; 4(5):407. PubMed ID: 4345756
[No Abstract] [Full Text] [Related]
27. Determination of silica-purified plasma calcitonin for the detection and management of medullary thyroid carcinoma: comparison of two provocative tests.
Gharib H; Kao PC; Heath H
Mayo Clin Proc; 1987 May; 62(5):373-8. PubMed ID: 3573825
[TBL] [Abstract][Full Text] [Related]
28. Determination of plasma calcitonin gene-related peptide concentrations by a new immunochemiluminometric assay in normal persons and patients with medullary thyroid carcinoma and other neuroendocrine tumors.
Carter WB; Taylor RL; Kao PC; Heath H
J Clin Endocrinol Metab; 1991 Feb; 72(2):327-35. PubMed ID: 1991803
[TBL] [Abstract][Full Text] [Related]
29. Alcohol-stimulated calcitonin release in medullary carcinoma of the thyroid.
Cohen SL; MacIntyre I; Grahame-Smith D; Walker JG
Lancet; 1973 Nov; 2(7839):1172-3. PubMed ID: 4127549
[No Abstract] [Full Text] [Related]
30. [Calcitonin determination as a possibility for the evaluation of surgical result in medullary thyroid carcinoma (C-cell carcinoma)].
Horn J; Pfarr B; Ziegler R
Langenbecks Arch Chir; 1975; Suppl():231-4. PubMed ID: 1207235
[TBL] [Abstract][Full Text] [Related]
31. [Prognostic values of the doubling time of serum carcinoembryonic antigen and calcitonin levels in medullary thyroid carcinoma].
Miyauchi A; Onishi T; Matsuzuka F; Hirai K; Kuma K; Takai S; Nakamoto K; Nakamura K; Nanjo S; Maeda M
Gan No Rinsho; 1986 Oct; 32(12):1519-24. PubMed ID: 3783976
[TBL] [Abstract][Full Text] [Related]
32. Secretory protein 7B2. A novel tumor marker of medullary carcinoma of the thyroid.
Ohashi M; Natori S; Fujio N; Iguchi H; Nawata H
Horm Metab Res; 1990 Feb; 22(2):114-6. PubMed ID: 2323727
[TBL] [Abstract][Full Text] [Related]
33. Calcitonin, calcitonin gene-related peptide, and gastrin-releasing peptide in familial thyroid medullary carcinoma.
Månsson B; Ahrén B; Nobin A; Böttcher G; Sundler F
Surgery; 1990 Feb; 107(2):182-6. PubMed ID: 2300897
[TBL] [Abstract][Full Text] [Related]
34. Effects of short-term subcutaneous administration of SMS 201-995 on calcitonin plasma levels in patients suffering from medullary thyroid carcinoma.
Guliana JM; Guillausseau PJ; Caron J; Siame-Mourot C; Calmettes C; Modigliani E
Horm Metab Res; 1989 Oct; 21(10):584-6. PubMed ID: 2807148
[No Abstract] [Full Text] [Related]
35. Calcitonin heterogeneity in lung cancer and medullary thyroid cancer.
Becker KL; Snider RH; Silva OL; Moore CF
Acta Endocrinol (Copenh); 1978 Sep; 89(1):89-99. PubMed ID: 211777
[TBL] [Abstract][Full Text] [Related]
36. Secretion of calcitonin and gastrin in rats with transplanted medullary thyroid carcinoma.
Normann T; Normann E; Schrumpf E; Gautvik KM
Acta Pathol Microbiol Scand A; 1977 Jan; 85A(1):63-72. PubMed ID: 835355
[TBL] [Abstract][Full Text] [Related]
37. Pentagastrin and glucagon stimulate serum somatostatin-like immunoreactivity in man.
Epstein S; Berelowitz M; Bell NH
J Clin Endocrinol Metab; 1980 Dec; 51(6):1227-31. PubMed ID: 6108330
[TBL] [Abstract][Full Text] [Related]
38. Plasma calcitonin and ACTH responses to lysine vasopressin, calcium and pentagastrin in a patient with medullary thyroid carcinoma associated with Cushing's syndrome.
Shimatsu A; Kato Y; Tanaka I; Nakai Y; Fukunaga M; Imura H
Clin Endocrinol (Oxf); 1983 Feb; 18(2):119-25. PubMed ID: 6133658
[TBL] [Abstract][Full Text] [Related]
39. The effects of L-dopa on in vitro and in vivo calcitonin release from medullary thyroid carcinoma.
Baylin SB; Hsu TH; Stevens SA; Kallman CH; Trump DL; Beaven MA
J Clin Endocrinol Metab; 1979 Mar; 48(3):408-14. PubMed ID: 218991
[TBL] [Abstract][Full Text] [Related]
40. Calcitonin and PDN-21 as tumour markers in MEN-2 family screening for medullary thyroid carcinoma.
Schifter S
Eur J Cancer; 1992; 28(2-3):341-5. PubMed ID: 1350454
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]